Relationship of Epicardial Adiposity With Sedentary Time, Physical Activity and Performance in Hypertensives

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-06

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epicardial adipose tissue is associated with the development of cardiovascular disease and its increase is positively correlated with blood pressure elevation in hypertensive individuals. In the literature, being physically active has been shown to be effective in the treatment of hypertension and reduction of epicardial adipose tissue thickness. The aim of this study was to evaluate the relationship between epicardial adipose tissue thickness and sedentary time, physical activity level and physical performance in patients with hypertension. The study included 40 patients with hypertension. The physical and demographic characteristics of the participants were collected using a sociodemographic form. Waist/hip circumference was measured with tape measure and epicardial adipose tissue thickness with echocardiography device. Physical activity levels and sedentary time were recorded via IPAQ-7. Physical performance was determined using the 30-s sit-and-stand test. There is no previous study in the literature evaluating the relationship between epicardial adipose tissue thickness and sedentary time and physical activity levels in hypertensive patients. With this study, we aim to contribute to the literature by filling this deficiency.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hyperventilation and Physical Performance in Obesity

NCT07122804

Obesity

RECRUITING

Relative Sarcopenia and Cardiometabolic Risk in Young Adults With Obesity

NCT04195061

Overweight and Obesity Insulin Resistance

COMPLETED

Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease

NCT00510588

Stable Coronary Artery Disease Obesity Impaired Glucose Tolerance

COMPLETED NA

HIIT in Sedentary Obese Adults: Effects on Metabolic Risk, Body Composition, and FABP4

NCT06973980

High-Intensity Interval Training

RECRUITING NA

Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease

NCT00510705

Severe Coronary Artery Disease Obesity Impaired Glucose Tolerance

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

INCREASED EPICARDIAL ADIPOSIS TISSUE

EPICARDIAL ADIPOSIS TISSUE AND PHYSICAL PERFORMANCE MEASUREMENT

Intervention Type DIAGNOSTIC_TEST

EPICARDIAL ADIPOSIS TISSUE AND PHYSICAL PERFORMANCE MEASUREMENT OF THE PARTICIPANTS WAS MADE.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EPICARDIAL ADIPOSIS TISSUE AND PHYSICAL PERFORMANCE MEASUREMENT

EPICARDIAL ADIPOSIS TISSUE AND PHYSICAL PERFORMANCE MEASUREMENT OF THE PARTICIPANTS WAS MADE.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteering to participate in the study
* Being diagnosed with hypertension for at least 6 months
* Speaking Turkish
* to be able to read and write,
* To be between 18-65 years old

Exclusion Criteria

* Severe valvular disease
* be heart failure
* being cardiomyopathy
* having chronic kidney disease
* being thyroid diseases
* active infectious or inflammatory diseases
* serious psychiatric illnesses such as panic disorder or major depression

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes